Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
BioMarin Pharmaceutical Inc. logo

BioMarin Pharmaceutical Inc.

Sector: Healthcare   

Industry: Biotechnology

75.90
 
USD
  
-0.55
  
(-0.72%)
Optionable: Yes  Market Cap: 14,685 M  90-day average vol: 1,632,204

Previous close: 76.45  Open: 76.17  Bid: 75.49  Ask: 76.98
52 week range    
75.03   
   99.56
Peers   
RARE / 
ESPR / 
SNY / 
SGMO / 
FOLD / 
Last updated: Friday 24th May 2024
47
MarketXLS Rank
40
Value
30
Technical
71
Quality

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

CPRX

1 B14.86.54

ESPR

0 B-0.43.42

FOLD

3 B-10.59.26

RARE

5 B-13.369.79

SGMO

1 B-4.75.72

SNY

Financials

BMRN Income Statement

Annual
Dec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22Dec-23
AcquisitionExpense359 M515 M
AllowancesForConstruction122 M
Amortization of intangibles157 M684 M554 M518 M492 M457 M-840000.038 M39 M
Basic EPS from continuing operations-0.92-1.07-3.8-0.67-0.44-0.134.75-0.350.760.89
Basic EPS total-0.92-1.07-3.8-0.67-0.44-0.134.75-0.350.760.89
Basic weighted shares outstanding146 M160 M166 M174 M177 M179 M181 M183 M185 M188 M
Cost of sales122 M152 M210 M242 M315 M359 M524 M471 M484 M515 M
Depreciation44 M50 M73 M76 M90 M89 M43 M46 M39 M40 M
DepreciationAndAmortization44 M50 M73 M76 M90 M89 M43 M46 M39 M40 M
DevelopmentExpense471 M
Diluted EPS total-0.92-1.07-3.81-0.67-0.44-0.134.53-0.350.750.87
Diluted normalized net income/share-3.81-0.67-0.44-0.134.53-0.350.750.87
Diluted weighted shares outstanding146 M166 M174 M177 M179 M192 M183 M189 M192 M
Earnings from equity interest-877000.0-817000.0-538000.0-1 M-553000.0-587000.0-6000.0
EarningsFromEquityInterestNetOfTax-877000.0-817000.0-538000.0-1 M-553000.0-587000.0-6000.0
ExciseTaxes152 M
GainOnSaleOfPPE25 M59 M108 M
GainOnSaleOfSecurity-100000.0
GeneralAndAdministrativeExpense302 M402 M477 M554 M604 M681 M738 M759 M854 M937 M
Gross operating profit627 M738 M907 M1,072 M1,176 M1,345 M1,336 M1,376 M1,612 M1,904 M
ImpairmentOfCapitalAssets130 M39 M
Income before tax-125 M-155 M-831 M-36 M-143 M-95 M-42 M-75 M150 M189 M
Income restructuring and M&A484 M
Income taxes9 M17 M-201 M81 M-65 M-71 M-901 M-11 M8 M21 M
Interest income6 M5 M7 M15 M23 M23 M17 M10 M18 M58 M
InterestExpenseNonOperating37 M38 M39 M43 M44 M23 M29 M15 M16 M17 M
InterestExpenseOperating524 M
LossAndLossAdjustmentExpectedIncurred471 M
MiscOtherSpecialCharges67 M369 M34 M125 M50 M25 M
Net income from total operations-134 M-172 M-630 M-117 M-77 M-24 M859 M-64 M142 M168 M
NetIncomeCommonStockholders-87 M-207 M-684 M-24 M20 M124 M992 M-64 M142 M168 M
NetIncomeContinuousOperations-134 M-172 M-630 M-117 M-77 M-24 M859 M-64 M142 M168 M
NetNonOperatingInterestIncomeExpense-31 M-34 M-32 M-28 M-21 M-712000.0-13 M-5 M2 M41 M
NonRecurringOperationExpense484 M
Normalized income-81 M98 M-223 M218 M-208 M169 M-1,003 M715 M
Operating income-93 M-111 M-803 M-15 M-124 M-100 M-37 M-82 M150 M158 M
Operating income before depreciation (EBITDA)-35 M-39 M-663 M130 M28 M46 M634 M57 M275 M305 M
OperatingExpense763 M1,047 M1,134 M1,157 M1,614 M1,748 M1,359 M1,376 M1,506 M2,209 M
Other income net56 M-170 M600 M-124 M-49 M-24 M-59 M-108 M13 M
OtherGandA302 M402 M477 M554 M604 M681 M738 M759 M854 M937 M
OtherImpairmentOfCapitalAssets199 M599 M13 M
OtherOperatingExpenses-279000.09 M-5 M-8 M-2 M-7 M-7 M-12 M2 M11 M
OtherWriteOff524 M
PromotionAndAdvertising30 M25 M28 M
RentAndLandingFees8 M9 M12 M11 M12 M
Research & development expense462 M635 M662 M611 M696 M715 M628 M629 M650 M747 M
ResearchExpense462 M635 M662 M611 M696 M715 M628 M629 M650 M747 M
RestructringAndMnAIncome484 M
Revenue per share157 M684 M554 M518 M492 M457 M-840000.038 M39 M
SalariesAndWages8 M11 M11 M315 M20 M20 M21 M22 M
Selling Gen & administrative expense302 M402 M477 M554 M604 M681 M738 M759 M854 M937 M
SellingAndMarketingExpense315 M30 M25 M28 M
Special income/charges-130 M-210 M-242 M-484 M-39 M
Total Income available for interest expense (EBIT)-88 M-116 M-792 M7 M-99 M-71 M511 M-60 M166 M206 M
Total common shares outstanding159 M162 M173 M176 M178 M180 M182 M184 M187 M189 M
Total net income-134 M-172 M-630 M-117 M-77 M-24 M859 M-64 M142 M168 M
Total ordinary shares190 M190 M190 M190 M190 M190 M190 M190 M190 M190 M
Total revenues749 M890 M1,117 M1,314 M1,491 M1,704 M1,860 M1,846 M2,096 M2,419 M
TotalExpenses886 M1,199 M1,343 M1,399 M1,929 M2,108 M1,883 M1,847 M1,989 M2,724 M
TotalRevenue749 M890 M1,117 M1,314 M1,491 M1,704 M1,860 M1,846 M2,096 M2,419 M
WriteOff210 M242 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University